These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 5585650

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M, Fukutomi O, Kondo N, Kato Z, Nakashima Y, Shinoda S, Agata H, Kondo T, Imaeda N, Orii T.
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW, Zech K, Fischer R.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Theophylline versus aminophylline in rectal administration.
    Touitou E, Yosselson-Superstine S.
    J Clin Hosp Pharm; 1985 Jun; 10(2):211-7. PubMed ID: 4019794
    [Abstract] [Full Text] [Related]

  • 8. Comparative serum theophylline levels following the oral administration of elixophyllin and somophyllino-O, a new preparation of aminophylline.
    Sherter C, Denefrio J.
    Curr Ther Res Clin Exp; 1974 Mar; 16(3):239-42. PubMed ID: 4206731
    [No Abstract] [Full Text] [Related]

  • 9. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC, Gotz VP, Robinson JD, Russell WL, Ryerson GG.
    Clin Pharm; 1983 Mar; 2(4):347-52. PubMed ID: 6883961
    [Abstract] [Full Text] [Related]

  • 10. [The pharmacokinetic characteristics of theophylline in patients with chronic nonspecific intestinal diseases in relation to its routes of administration into the gastrointestinal tract].
    Kukes VG, Fazylov AV, Kirkin BV, Kurapov AP, Blinov IL.
    Ter Arkh; 1993 Mar; 65(2):52-4. PubMed ID: 9133013
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D, Molz KH, Staib AH, Rietbrock N.
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [Abstract] [Full Text] [Related]

  • 13. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline.
    Chang KC, Chai H, Miles-Lawrence R, Bell TD, Pinney CT.
    Ann Allergy; 1982 Dec; 49(6):315-7. PubMed ID: 7149347
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous aminophylline.
    Van Dellen RG.
    Chest; 1979 Jul; 76(1):2-3. PubMed ID: 446166
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma theophylline levels in asthmatic children in Singapore. A preliminary study.
    Lee HS, Ngiam TE.
    Singapore Med J; 1983 Oct; 24(5):276-9. PubMed ID: 6669990
    [No Abstract] [Full Text] [Related]

  • 20. [Serum concentrations of theophylline in different techniques of treatment with its derivatives (author's transl)].
    Král B, Tichý M, Eliás J, Simsa J, Tilser P, Jezek S, Pleskot M.
    Cas Lek Cesk; 1981 Oct 22; 120(42):1287-90. PubMed ID: 7344805
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.